These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27694978)

  • 1. Precision medicine from the renal cancer genome.
    Riazalhosseini Y; Lathrop M
    Nat Rev Nephrol; 2016 Nov; 12(11):655-666. PubMed ID: 27694978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; RouprĂȘt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a genome-based treatment landscape for renal cell carcinoma.
    Massari F; Di Nunno V; Santoni M; Gatto L; Caserta C; Morelli F; Zafarana E; Carrozza F; Mosca A; Mollica V; Iacovelli R; Sabbatini R; Porta C; Bracarda S
    Crit Rev Oncol Hematol; 2019 Oct; 142():141-152. PubMed ID: 31401421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
    Linehan WM; Ricketts CJ
    Nat Rev Urol; 2019 Sep; 16(9):539-552. PubMed ID: 31278395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics and epigenomics of renal cell carcinoma.
    Maher ER
    Semin Cancer Biol; 2013 Feb; 23(1):10-7. PubMed ID: 22750267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Management of Hereditary Renal Cell Cancer.
    Menko FH; Maher ER
    Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile.
    Cifola I; Spinelli R; Beltrame L; Peano C; Fasoli E; Ferrero S; Bosari S; Signorini S; Rocco F; Perego R; Proserpio V; Raimondo F; Mocarelli P; Battaglia C
    Mol Cancer; 2008 Jan; 7():6. PubMed ID: 18194544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited forms of renal cell carcinoma.
    Kiuru M; Kujala M; AittomÀki K
    Scand J Surg; 2004; 93(2):103-11. PubMed ID: 15285561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma deep sequencing: recent developments.
    Farber LJ; Furge K; Teh BT
    Curr Oncol Rep; 2012 Jun; 14(3):240-8. PubMed ID: 22535504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics of renal cell cancer: the biology behind and the therapy ahead.
    Jones J; Libermann TA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
    Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
    AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology.
    Su D; Singer EA; Srinivasan R
    Curr Opin Oncol; 2015 May; 27(3):217-23. PubMed ID: 25811348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour and patient factors in renal cell carcinoma-towards personalized therapy.
    Haddad AQ; Margulis V
    Nat Rev Urol; 2015 May; 12(5):253-62. PubMed ID: 25868564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential reinforcement active feature learning for gene signature identification in renal cell carcinoma.
    Huang M; Ye X; Imakura A; Sakurai T
    J Biomed Inform; 2022 Apr; 128():104049. PubMed ID: 35283266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.